EUVIMEDEUVIMED entdecken
Crossref

99m Tc-MIP-1404 SPECT/CT Companion Diagnostic for 177 Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer

Thorsten Derlin, Liam Widjaja, Nina Natascha Harke, Christoph Czerner, Desiree Weiberg, Tobias L Ross, Frank M Bengel

Journal of Nuclear Medicine · 2025

DOI: 10.2967/jnumed.124.269319 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2025. Verfasst von Thorsten Derlin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany; and derlin.thorsten@mh-hannover.de. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Castration-Resistant, Single Photon Emission Computed Tomography Computed Tomography, Lutetium, Organotechnetium Compounds. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic Neoplasms, Castration-ResistantSingle Photon Emission Computed Tomography Computed TomographyLutetiumOrganotechnetium CompoundsGlutamate Carboxypeptidase IIHumansMaleAgedMiddle AgedRetrospective StudiesNeoplasm MetastasisAged, 80 and overRadioisotopesRadiopharmaceuticalsProstate-Specific Antigen

Stichwörter der Autor:innen

Lu-PSMASPECTprostate-specific membrane antigen (PSMA)radiopharmaceutical therapyscintigraphy

Substanzen

LutetiumPluvictoLutetium-177RadioisotopesRadiopharmaceuticalsOrganotechnetium CompoundsGlutamate Carboxypeptidase IIProstate-Specific Antigen

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany; and derlin.thorsten@mh-hannover.de.
  • Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany; and.
  • Department of Urology, Hannover Medical School, Hannover, Germany.

Zitieren

APA

Derlin, T., Widjaja, L., Harke, N. N., Czerner, C., Weiberg, D., Ross, T. L., & Bengel, F. M. (2025). 99m Tc-MIP-1404 SPECT/CT Companion Diagnostic for 177 Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.124.269319

Vancouver

Derlin T, Widjaja L, Harke NN, Czerner C, Weiberg D, Ross TL, et al. 99m Tc-MIP-1404 SPECT/CT Companion Diagnostic for 177 Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer. Journal of Nuclear Medicine. 2025. doi:10.2967/jnumed.124.269319

BibTeX
@article{Derlin2025,
  author = {Derlin, Thorsten and Widjaja, Liam and Harke, Nina Natascha and Czerner, Christoph and Weiberg, Desiree and Ross, Tobias L and Bengel, Frank M},
  title = {99m Tc-MIP-1404 SPECT/CT Companion Diagnostic for 177 Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer},
  journal = {Journal of Nuclear Medicine},
  year = {2025},
  doi = {10.2967/jnumed.124.269319}
}
Kostenlos starten →